Literature DB >> 26545835

Morcellation of uterine leiomyomas: a plea for patient triage.

Frédéric Amant1, Thierry Van den Bosch2, Ignace Vergote3, Dirk Timmerman3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26545835     DOI： 10.1016/S1470-2045(15)00375-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

Review 1.  Circulating Transcripts and Biomarkers in Uterine Tumors: Is There a Predictive Role?

Authors:  Christine De Bruyn; Thaïs Baert; Thierry Van den Bosch; An Coosemans
Journal:  Curr Oncol Rep       Date:  2020-01-29       Impact factor: 5.075

Review 2.  Ultrasound-Guided Trans-Uterine Cavity Core Needle Biopsy of Uterine Myometrial Tumors to Differentiate Sarcoma from a Benign Lesion-Description of the Method and Review of the Literature.

Authors:  Maciej Stukan; Piotr Rutkowski; Jeremy Smadja; Sylvie Bonvalot
Journal:  Diagnostics (Basel)       Date:  2022-05-29

Review 3.  Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions.

Authors:  Klaudia Żak; Bartłomiej Zaremba; Alicja Rajtak; Jan Kotarski; Frédéric Amant; Marcin Bobiński
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.575

4.  Integrative Genomic and Transcriptomic Profiling Reveals a Differential Molecular Signature in Uterine Leiomyoma versus Leiomyosarcoma.

Authors:  Alba Machado-Lopez; Roberto Alonso; Victor Lago; Jorge Jimenez-Almazan; Marta Garcia; Javier Monleon; Susana Lopez; Francisco Barcelo; Amparo Torroba; Sebastian Ortiz; Santiago Domingo; Carlos Simon; Aymara Mas
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

5.  Endometrial Sampling for Preoperative Diagnosis of Uterine Leiomyosarcoma.

Authors:  Rosanne M Kho; Vrunda B Desai; Peter E Schwartz; Jason D Wright; Cary P Gross; Lindsey M Hutchison; Francis P Boscoe; Haiqun Lin; Xiao Xu
Journal:  J Minim Invasive Gynecol       Date:  2021-07-13       Impact factor: 4.137
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.